It all begins here.
Contracting out your PK and PK-PD studies is a serious commitment.
Having high-quality results available on a timely basis is an essential part of adapting to the many hurdles that may arise throughout drug development.
And indeed, to meet this standard a lab must be equipped to thoughtfully plan, design, and carry out multiple studies simultaneously. Technical expertise will be a requirement to implement and analyze these studies, ranging from simple to state-of-the-art.
So why entrust your antimicrobial to an academic institution lacking in capacity or an industry lab without specialized expertise?
At the intersection of academia and industry.
We have created a fully-equipped antimicrobial PK-PD facility.
And we staffed it with first-class scientists to deliver results quickly and reliably — in so doing, we generate knowledge about your drug and minimize risk.
In fact, we perform...
- Analytical drug assays
Including Biological, Chemical (e.g., LC/MS-MS), and Protein Binding Assays
- In vitro screening of candidate drugs for microbiologic activity and static time-kill studies
Including Cell Culture, Drug Susceptibility, Mutation Frequency, and Plaque Assays
- In vitro infection models
Including One-Compartment Chemostat and Hollow Fiber
- In vivo PK-PD infection models
Including the most common translational models